SSC-COVID in Patients After COVID-19
High Incidence of Secondary Sclerosing Cholangitis in Hospitalized "First-wave" COVID-19 Patients: a Retrospective Single Center Study
1 other identifier
observational
64
1 country
1
Brief Summary
Analysis of occurrence of SSC-COVID in SARS-CoV-2-patients after the first wave of COVID-pandemic
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2022
CompletedFirst Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedFebruary 10, 2022
February 1, 2020
1.8 years
February 9, 2022
February 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of SSC-COVID in hospitalized COVID-patients of the first wave
While Follow-up-session controlled clinical and laboratory parameters
one and a half year
Study Arms (1)
post-COVID-patients
Interventions
Eligibility Criteria
This is a study of adult patients who participated in the COVID-19 outpatient clinic at the University Hospital of Tübingen as part of the follow-up examinations after COVID-19 disease. In particular, the development of liver enzymes was analysed.
You may qualify if:
- post-COVID19-patients with required hospitalization during the first wave of COVID-19-pandemic
- patients controlled at the university ambulance for follow-up
You may not qualify if:
- children and patients younger than 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Tuebingen
Tübingen, 72076, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2022
First Posted
February 10, 2022
Study Start
March 1, 2020
Primary Completion
December 31, 2021
Study Completion
January 31, 2022
Last Updated
February 10, 2022
Record last verified: 2020-02